DTC Ads May Extend Product Life Without Rx-To-OTC Switch – Pfizer’s Gelbert
This article was originally published in The Pink Sheet Daily
Executive Summary
Increased consumer “branding” of Rx drugs may temper the need for OTC switch, Pfizer Consumer Healthcare VP says. Despite profit drop following loss of exclusivity, a drug’s continued Rx status may provide long-term benefits that “outrun” its potential as an OTC.